Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison.

Mease, Philip; Choy, Ernest; Nash, Peter; Kalyvas, Chrysostomos; Hunger, Matthias; Pricop, Luminita; Gandhi, Kunal K; Jugl, Steffen M; Thom, Howard

Mease, Philip; Choy, Ernest; Nash, Peter; Kalyvas, Chrysostomos; Hunger, Matthias; Pricop, Luminita; Gandhi, Kunal K; Jugl, Steffen M; Thom, Howard.

Afiliación

Mease P; Swedish Medical Center and University of Washington, Seattle, WA, USA.
Choy E; CREATE Centre, Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK.
Nash P; University of Queensland, Brisbane, Queensland, Australia.
Kalyvas C; ICON plc (formerly Mapi Group), Houten, Netherlands.
Hunger M; ICON plc (formerly Mapi Group), Houten, Netherlands.
Pricop L; ICON plc (formerly Mapi Group), Munich, Germany.
Gandhi KK; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Jugl SM; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Thom H; Novartis Pharma AG, Basel, Switzerland.

Eur J Rheumatol ; 6(3): 113-121, 2019 07.

Article en En | MEDLINE | ID: mdl-31364979

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Eur J Rheumatol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google